$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
Stefan Oelrich acknowledges challenge of its two bestselling products going off patent
Collaboration will help German group deliver several hundred million doses after lagging behind competitors
Paying up to $4bn for US-based biotech is unlikely to be transformational
German group acquires US-based AskBio to strengthen its lucrative pharma business
It is hard to see what would trigger a near-term turnround in investor sentiment
German group warns coronavirus crisis to hit harder than expected as it writes down assets in agricultural business
Unpredictable juries expose potential hazards of German conglomerate’s approach
German group will spend up to $10.9bn to settle lawsuits over Roundup
Shareholders would be within their right to agitate for radical change.
Chief executive of German group says deal will ‘bring a long period of uncertainty to an end’
Shortages of antimalarials and inhalers feared as purchases spike
Two shareholders seek damages for directors’ alleged personal responsibility for corporate misconduct
Rise in plaintiffs comes as German chemicals group reports 19% jump in sales
Farmers voiced concerns on social media over alleged data sharing
German chemicals group faces surge in plaintiffs alleging cancer link to Roundup
Farmer’s claims could expand pharma group’s legal woes over Monsanto acquisition
Too many giants of the Dax are suffering from self-inflicted wounds
Deal will create second-biggest player in sector as German chemicals group looks to reorganise
German chemicals and pharma group has been under strain amid claims weedkiller causes cancer
Deal values BlueRock Therapeutics at $1bn
Welcome to Due Diligence, the FT’s daily deals briefing
With the disastrous purchase of Monsanto and plummeting shares, some question if it is time to break up the German group
Pharma and chemicals group says it will ‘defend itself vigorously’ amid mounting cases
Damages award reduced to $87m in partial victory for German chemicals company
Yellow Wood to snap up the maker of shoe inserts for almost $600m
International Edition
